Literature DB >> 15952716

Proteomic studies on low- and high-grade human brain astrocytomas.

Federico Odreman1, Marco Vindigni, Marlen Lujardo Gonzales, Benedetta Niccolini, Giovanni Candiano, Bruno Zanotti, Miran Skrap, Stefano Pizzolitto, Giorgio Stanta, Alessandro Vindigni.   

Abstract

Human brain astrocytomas range from the indolent low-grade to the highly infiltrating and aggressive high-grade form, also known as glioblastoma multiforme. The extensive heterogeneity of astrocytic tumors complicates their pathological classification. In this study, we compared the protein pattern of low-grade fibrillary astrocytomas to that of glioblastoma multiforme by 2D electrophoresis. The level of most proteins remains unchanged between the different grade tumors and only few differences are reproducibly observable. Fifteen differentially expressed proteins, as well as seventy conserved spots, were identified by mass spectrometry. Western and immnunohistochemical analysis confirmed the differential expression of the identified proteins. These data provide an initial reference map for brain gliomas. Among the proteins more highly expressed in glioblastoma multiforme, we found peroxiredoxin 1 and 6, the transcription factor BTF3, and alpha-B-crystallin, whereas protein disulfide isomerase A3, the catalytic subunit of the cAMP-dependent protein kinase, and the glial fibrillary acidic protein are increased in low-grade astrocytomas. Our findings contribute to deepening our knowledge of the factors that characterize this class of tumors and, at the same time, can be applied toward the development of novel molecular biomakers potentially useful for an accurate classification of the grade of astrocytomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952716     DOI: 10.1021/pr0498180

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  36 in total

1.  Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression.

Authors:  Chul-Kee Park; Jin Hyun Kim; Min Jeong Moon; Ji Hye Jung; Su-Young Lim; Sung-Hye Park; Jong-Hoon Kim; Dong Gyu Kim; Hee-Won Jung; Byung-Kyu Cho; Sun Ha Paek
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-26       Impact factor: 4.553

Review 2.  Proteomic analysis in cancer research: potential application in clinical use.

Authors:  Jesús García-Foncillas; Eva Bandrés; Ruth Zárate; Natalia Remírez
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

3.  Assessing Amide Proton Transfer (APT) MRI Contrast Origins in 9 L Gliosarcoma in the Rat Brain Using Proteomic Analysis.

Authors:  Kun Yan; Zongming Fu; Chen Yang; Kai Zhang; Shanshan Jiang; Dong-Hoon Lee; Hye-Young Heo; Yi Zhang; Robert N Cole; Jennifer E Van Eyk; Jinyuan Zhou
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

Review 4.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

5.  Clinicopathological significance of BTF3 expression in colorectal cancer.

Authors:  Chao-Jie Wang; Hanna Frånbergh-Karlson; Da-Wei Wang; Gunnar Arbman; Hong Zhang; Xiao-Feng Sun
Journal:  Tumour Biol       Date:  2013-03-27

6.  Multifarious proteomic signatures and regional heterogeneity in glioblastomas.

Authors:  Chul-Kee Park; Ji Hye Jung; Sung-Hye Park; Hee-Won Jung; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2009-02-15       Impact factor: 4.130

7.  Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.

Authors:  Sally Järvelä; Immo Rantala; Alejandra Rodriguez; Heini Kallio; Seppo Parkkila; Vuokko L Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

8.  Expression of αB-crystallin overrides the anti-apoptotic activity of XIAP.

Authors:  Jee Suk Lee; Hye Young Kim; Na Young Jeong; Sang Yeob Lee; Young Geol Yoon; Yung Hyun Choi; Chunlan Yan; In-Sun Chu; Hyungjong Koh; Hwan Tae Park; Young Hyun Yoo
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

9.  Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype.

Authors:  Carl Wibom; Lina Mörén; Mads Aarhus; Per Morten Knappskog; Morten Lund-Johansen; Henrik Antti; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2009-04-07       Impact factor: 4.130

10.  Exploratory Visual Analysis of statistical results from microarray experiments comparing high and low grade glioma.

Authors:  David M Reif; Mark A Israel; Jason H Moore
Journal:  Cancer Inform       Date:  2007-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.